Mayne Pharma more than doubles FY losses
SYDNEY: Drugs manufacturer Mayne Pharma has more than doubled its full-year losses after the pharmaceutical
SYDNEY: Drugs manufacturer Mayne Pharma has more than doubled its full-year losses after the pharmaceutical
FEATURED
Hospitals morphing into wellness and health precincts
Developers release plans for latest bayside living proposal
Technology will help urban spaces adapt in an ever-changing world
New funding agency to ‘supercharge’ community housing providers
Drug company deal delivers hope for dementia patients
Proactive alliances among stakeholders can lead to assisted living departments
INNOVATION
